Genzyme shares hit 52-week high By: MarketWatch March 08, 2011 at 12:07 PM EST Stock touches high after board recommends shareholders take Sanofi Aventis $74-a-share offer. Read More >> Related Stocks: Macy's Sanofi-Aventis S.A. ADR Vertex Pharmaceuticals